Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

Gemcitabine (G) and docetaxel (D) are commonly used to treat recurrent/metastatic soft tissue sarcoma. This study tested the hypothesis that outcomes would be improved by addition of bevacizumab (B). The initial design was randomized double-blind trial of G + D + B versus G + D + placebo. Due to slo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickson, Mark A., D'Adamo, David R., Keohan, Mary L., D'Angelo, Sandra P., Carvajal, Richard D., Gounder, Mrinal M., Maki, Robert G., Qin, Li-Xuan, Lefkowitz, Robert A., McKennon, Olivia R., Hirst, Catherine M., Schwartz, Gary K., Tap, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446476/
https://www.ncbi.nlm.nih.gov/pubmed/26074722
http://dx.doi.org/10.1155/2015/532478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446476/
https://www.ncbi.nlm.nih.gov/pubmed/26074722
http://dx.doi.org/10.1155/2015/532478

Ejemplares similares